Improvement in study participants’ glycaemic control (HbA1c), reduction in serious adverse events
(severe hypoglycaemia and hyperglycaemia/Diabetic Ketoacidosis (DKA)), and improved quality of life.
Rwanda Diabetes Association, All right reserved.
Designed By HOMIEZ